Bortezomib improves outcome after SCT in multiple myeloma patients with end-stage renal failure.
Breitkreutz I, Heiss C, Perne A, Beimler J, Jäger D, Egerer G, Ho AD, Neben K, Zeier M, Goldschmidt H, Raab MS.
Breitkreutz I, et al. Among authors: goldschmidt h.
Bone Marrow Transplant. 2014 Nov;49(11):1371-5. doi: 10.1038/bmt.2014.165. Epub 2014 Aug 4.
Bone Marrow Transplant. 2014.
PMID: 25089594